GlobeNewswire

BAHAMAS MINISTRY OF TOURISM AND AVIATION DIRECTOR GENERAL JOY JIBRILU HONORED WITH CARIBBEAN TOURISM ORGANIZATION'S ALLIED AWARD

Dela

Jibrilu became the first Bahamian member of the Caribbean Tourism Organization to receive the Allied Award for sustainable development at Caribbean Week New York

Plantation, FL, June 08, 2018 (GLOBE NEWSWIRE) -- Last night during the Caribbean Tourism Industry Awards Dinner and Fashion Show, part of the annual Caribbean Week New York events, Bahamas Ministry of Tourism and Aviation Director General Joy Jibrilu received the distinguished Allied Award for her exceptional work towards the sustainable development of Caribbean tourism. 

Director General Jibrilu was present at the ceremony at the Wyndham New Yorker in Midtown to accept the award bestowed upon her by the Caribbean Tourism Organization (CTO) and its Allied Members. Mrs. Jibrilu is the first Bahamian member of the CTO family to receive the esteemed award.

"I am extremely honored to be receiving the Caribbean Tourism Organization's Allied Award this year," said Mrs. Jibrilu. "Promoting our spectacular Caribbean region and its sustainability is a personal passion of mine, and its good stewardship is essential for all of us. I am grateful that my colleagues in the tourism industry, and my neighbors in the Caribbean, consider my contributions to have been so worthwhile."

Established in 2005, the Allied Award is presented to an individual within the CTO who has done an extraordinary job of contributing to the sustainable development of the region. Eligible organizations include members of government, member airlines and cruise lines, and allied members, which includes hotels, tour operators, marketing companies, newspapers, magazines and television programming. 

"It is with both respect and admiration that we recognize these business and industry icons for their tireless commitment - often beyond the call of duty - to the development of a sustainable Caribbean tourism product," said Sylma Brown, Director, CTO-USA.

Throughout her tenure in the government sector, Mrs. Jibrilu has worked diligently to encourage sustainable development and tourism growth for The Islands Of The Bahamas, with a focus on respect to the local environment, culture and people. In her role as Director General, a position appointed to her in May 2014, she has had oversight in the development, marketing and promotion of the Bahamian Tourism Industry's multi-faceted marketing programs targeting consumers in global markets including the U.S., Canada, the U.K., Latin America and Europe.

Prior to this, she served as the Director of Investments in the Bahamas Investment Authority (BIA), Office of the Prime Minister, commencing that role in July 2008. 

In both positions, she has been involved in negotiating and implementing some of the largest tourism investment and development projects in the country, including the final phases of the Atlantis Paradise Island mega resort and the multi-billion dollar Baha Mar resort development on Cable Beach. 

Director General Jibrilu's contributions to these major tourism initiatives have brought significant employment and economic opportunity to The Bahamas, and by extension, the Caribbean region. She is passionate about The Bahamas, the Caribbean region and promoting her country, and the region around the world.  

"I am a firm believer that we are all guardians of these wonderful islands that many of us get to call home, and as a result, we have an incredible responsibility to promote tourism in the most sustainable manner in order to safeguard the Caribbean for future generations," Mrs. Jibrilu said. 

The Director General was one of nine industry and business professionals, in addition to 12 travel influencers from the media, to be recognized across several award categories during the event. Haitian-American Marlie Hall, an award-winning broadcast journalist and entrepreneur, alongside a former correspondent for CBS News, presided as Master of Ceremonies.

About Caribbean Week New York

Caribbean Week New York is the largest regional tourism activity in the New York area. Artists, performers, celebrity chefs, the Diaspora community, investors and other strategic partners join government officials, tourism stakeholders and the media for a week of festivities, raising awareness for the Caribbean's diverse tourism industry and provide opportunities. Member destinations will have the opportunity to promote their individual products and services, participate in meetings, seminars and other business development activities to further enhance the Caribbean brand, and provide updates and critical support to the travel agents and media who influence key travel demographics in the region's #1 source market.

For more information on Caribbean Week and a full program of events, visit www.onecaribbean.org. Visit www.Bahamas.com and follow The Bahamas on FacebookTwitter and YouTube

Weber Shandwick Public Relations: Bahamas@webershandwick.com

Attachment

Anita Johnson-Patty
Bahamas Ministry of Tourism
954-236-9292
ajohnson@bahamas.com




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Bahamas Ministry of Tourism via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum